Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

Share Price is delayed by 15 minutes
Get Live Data
19.50    0.25 (1.30%)
Bid:
19.00
Ask:
20.00
Spread: 1.00 (5.263%)
Market Cap: £17.48m
IHC Live PriceLast checked at - London Stock Exchange

Intraday Inspiration Hlt Share Chart

Schedule One - Inditherm plc

8 Jun 2015 07:30

RNS Number : 4228P
AIM
08 June 2015
 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

 

Inditherm plc (to be renamed Inspiration Healthcare Group plc) (the "Company")

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

 

Inditherm House

Houndhill Park

Bolton Road

Rotherham S63 7LG

 

COUNTRY OF INCORPORATION:

 

UK

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

 

www.inditherm.co.uk (up to Admission)

 

www.inspiration-healthcare.com (with effect from Admission)

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

 

Inditherm plc ("Inditherm") has agreed to acquire the entire issued share capital of Inspiration Healthcare Limited ("IHL") with effect from Admission through a reverse takeover.

 

IHL was founded in Leicestershire in 2003 as a medical device distribution company focused on innovative products for critical care. The company now provides a range of products for critical care, specialised surgical procedures and parenteral feeding through distribution agreements typically covering the UK and the Republic of Ireland. IHL also has a range of own-branded products focused on critical care which are sold in over 40 countries. In addition, IHL has a technical support business maintaining and repairing medical equipment.

 

Inditherm was formed in 1998 and was admitted to AIM in December 2001, having developed a heating product using new technology, also called Inditherm. Inditherm manufactures and licenses its heating technology for use in numerous applications that require temperature maintenance and stability. The principal applications lie in the following markets:

 

· Medical - operating theatres, neonatal and obstetrics; and

· Industrial - Inditherm provides a range of standard low voltage heating products for intermediate bulk containers, drums and the warming of gas bottles.

 

The Company's main country of operation is the UK.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

 

30,667,548 ordinary shares of 10 pence each.

 

No shares held in treasury.

 

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

 

No capital to be raised on admission.

 

Anticipated market capitalisation on Admission (based on an Inditherm share price of 4.375p) £13.4 million

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

 

83.4%

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:

 

None

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

 

Mark Simon Abrahams (Non-Executive Chairman)

Neil James Campbell (Chief Executive Officer)

Ian Douglas Smith (Finance Director and Company Secretary)

Toby Foster (Sales Director)

William Norman Brook Nolson (Non-Executive Director)

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

Before Admission

After Admission

%

%

Neil James Campbell1

Nil

19.56%

Toby Foster1

Nil

19.56%

Simon Guy Motley1

Nil

19.56%

Malcolm John Oxley1

1Nil

19.56%

William Graham Walls1

Nil

5.08%

Dion G Steward

29.40%

4.91%

Patrick J O'Grady

9.50%

1.58%

Stuart Hawthorne

4.90%

0.82%

Spreadex Limited

4.60%

0.77%

 

 

1 Deemed a concert party for the purposes of the Takeover Code

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

 

Deciduous Limited

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

 

(i) 31 December

 

(ii) Inspiration: 31 January 2015

Inditherm: 31 December 2015

 

(iii) By 30 September 2015: unaudited half yearly report to 30 June 2015

 

By 30 June 2016: audited annual report and financial statements to 31 December 2015

 

By 30 September 2016: unaudited half yearly report to 30 June 2016

 

EXPECTED ADMISSION DATE:

 

24 June 2015

 

NAME AND ADDRESS OF NOMINATED ADVISER:

 

WH Ireland Limited, 24 Martin Lane, London EC4R 0DR

 

NAME AND ADDRESS OF BROKER:

 

WH Ireland Limited, 24 Martin Lane, London EC4R 0DR

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

 

The admission document is available in electronic format from www.inditherm.co.uk/investor-relations. The admission document contains full details about the Company and the admission of its securities.

 

DATE OF NOTIFICATION:

 

8 June 2015

 

NEW/ UPDATE:

 

New

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PAAUVUSRVNANRAR
Date   Source Headline
24th May 20237:00 amRNSAppointment of Nominated Adviser and Broker
17th May 20237:00 amRNSMello investor conference
4th May 20237:00 amRNSInvestor Day
3rd May 20237:00 amRNSFinal Results
6th Apr 20235:53 pmRNSGrant of Options
3rd Apr 20235:53 pmRNSGrant of Options
31st Mar 20236:27 pmRNSExercise of Options & Issue of Equity
23rd Mar 20237:00 amRNSLaunch of range extension of neonatal ventilators
1st Mar 20237:00 amRNSChange of Website
17th Feb 20232:05 pmRNSTR1 Notification
16th Feb 20237:00 amRNSTrading Update
9th Dec 20222:27 pmRNSTR1 Notification
8th Dec 20221:10 pmRNSTR1 Notification
5th Dec 20227:00 amRNSBoard Changes
30th Nov 202210:28 amRNSDirector / PDMR Dealing
28th Nov 20222:05 pmRNSSecond Price Monitoring Extn
28th Nov 20222:00 pmRNSPrice Monitoring Extension
28th Nov 20229:05 amRNSSecond Price Monitoring Extn
28th Nov 20229:00 amRNSPrice Monitoring Extension
28th Nov 20227:00 amRNSUpdate on Trading
9th Nov 20227:00 amRNSUkraine Order
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
4th Oct 20222:05 pmRNSSecond Price Monitoring Extn
4th Oct 20222:00 pmRNSPrice Monitoring Extension
4th Oct 202211:05 amRNSSecond Price Monitoring Extn
4th Oct 202211:00 amRNSPrice Monitoring Extension
4th Oct 20227:00 amRNSInterim Results
21st Sep 20227:00 amRNSSignificant Japanese Order
1st Sep 20227:00 amRNSResults date and Investor events
15th Aug 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSCapital Markets Day
30th Jun 202212:58 pmRNSResult of AGM
30th Jun 20227:00 amRNSAGM Statement
10th Jun 20221:00 pmRNSExercise of options and Total Voting Rights
7th Jun 20227:00 amRNS£1.3 million Iraq Order
6th Jun 20227:00 amRNSAnnual Report 2022 and Notice of AGM
24th May 20227:00 amRNSTR1 Notification
20th May 20223:09 pmRNSTR1 Notification
19th May 20227:00 amRNSMello Investor Conference
4th May 20227:00 amRNSFinal Results
25th Apr 20227:05 amRNSInvestor Presentation
8th Apr 20222:21 pmRNSGrant of Options
1st Apr 20227:00 amRNSLaunch of test to avoid hearing loss in neonates
17th Feb 20227:00 amRNSPost Period Trading Update and Notice of Results
14th Feb 20227:00 amRNS$1.37 million Egyptian Order
1st Feb 20229:00 amRNSCenkos Virtual Growth and Innovation Forum
9th Dec 20214:15 pmRNSTR1 Notification
9th Dec 20214:15 pmRNSTR1 Notification
2nd Dec 20217:00 amRNSCapital Markets Day

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.